explore -WSS

explore

author：focus 2025-09-30 00:51:10 - browse：472

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Why hospitals are withdrawing from US News rankings

WSS

Custom gene therapy hints at new path for rare disease treatments

AI can’t replace a physician’s gut feeling

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Biden tests positive for Covid

Dozens dead from Maui wildfires: What we know about the victims

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

focus

explore

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

After Optum profits sink, UnitedHealth makes changes

Duchenne breakthrough therapy leaves behind pioneering families

Illumina slashes 2023 revenue projections yet again

State Dept. review finds Biden bears some blame for Afghanistan failures

Google and Epic fight stronger regulation of AI in health care

Guidelines to prevent youth baseball injuries need more muscle

Megan Rapinoe shares emotional post following US Women's World Cup exit

New air purifier tech could be key to improving indoor air quality

How Medicaid coverage policies for immigrants impact new moms

Wikipedia

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Illumina slashes 2023 revenue projections yet again

In early work, researchers turn to CRISPR to treat Alzheimer's

Key House panel plots a new health care package

Medicare to cover more brain scans for Alzheimer’s patients

How Medicaid coverage policies for immigrants impact new moms

hotspot

explore

hotspot

explore